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Café-au-lait Patches and Senile 
Plaques: How APPt the Connection?
Ganesh Diwakar1 and Thomas J. Hornyak1
Neurofibromatosis type 1 (NF1) is a genetic disease caused by mutations in the 
NF1 gene, which encodes the protein neurofibromin. Patients exhibit character-
istic hyperpigmented patches called café-au-lait patches. Melanocytes of NF1 
patients differ from normal human melanocytes, but no differences account 
completely for lesional hyperpigmentation. An association between β-amyloid 
precursor protein (APP) and neurofibromin, and their localization to the mela-
nosome, may help explain the development of café-au-lait patches.
Journal of Investigative Dermatology (2006) 126, 547–550. doi:10.1038/sj.jid.5700165
The nature of café-au-lait lesions in 
neurofibromatosis type 1 (NF1) has 
interested investigators for decades. 
NF1 is an autosomal dominant genetic 
disease characterized by a number of 
different abnormalities affecting vari-
ous organ systems and tissues in addi-
tion to the characteristic hyperpig-
mented — or café-au-lait, as they will 
be referred to here — macules and 
patches. These abnormalities include 
benign neoplasms such as dermal neu-
rofibromas and optic gliomas, as well 
as a predisposition to malignancies 
such as pheochromocytomas and juve-
nile myeloid leukemia. NF1 is associ-
ated with mutations in the human NF1 
gene. NF1 encodes the protein neuro-
fibromin, a large, 260-kilodalton tumor 
suppressor protein containing a Ras–
GTPase-activating protein (RasGAP) 
domain. Perhaps the best-understood 
biochemical function of neurofibromin 
is its activity as a negative regulator of 
Ras, accelerating the conversion of 
active, guanosine triphosphate-bound 
Ras to inactive, guanosine diphos-
phate-bound Ras (DeClue et al., 1992). 
The cellular abnormalities that result 
in various clinical manifestations of 
NF1 have been attributed to hyperac-
tive Ras activity due to loss-of-function 
mutations or deletions of one or both 
NF1 alleles.
Early studies of café-au-lait patches 
focused on characterizing their den-
sity and morphology and revealed 
two surprising observations: (1) not 
only did the café-au-lait patch often 
have a somewhat higher number of 
melanocytes than the normal skin of 
historical controls, but so did the rest 
of the skin in these patients; and (2) 
virtually all of the melanocytes visual-
ized in the epidermis of NF1 patients, 
whether lesional or non-lesional, 
contained enlarged pigment granules 
(Benedict et al., 1968; Martuza et al., 
1985). Both melanocyte and kerati-
nocyte numbers were quantified in 
lesional and non-lesional skin of NF1 
patients as well as the skin of normal 
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control individuals. NF1 patients had 
an increased density of melanocytes 
in both their lesional and their non-
lesional skin, effectively demonstrat-
ing that they possessed a smaller epi-
dermal melanin unit than unaffected 
controls. However, only half of NF1 
patients were found to have a statisti-
cally significant, modest increase in 
the numbers of melanocytes within 
café-au-lait lesions compared with 
unaffected skin (Benedict et al., 1968; 
Frenk and Marazzi, 1984).
Ultrastructural analysis of giant 
pigment granules, variously called 
macromelanosomes (Jimbow et al., 
1973) and melanin macroglobules 
(Martuza et al., 1985), within NF1 
melanocytes revealed that they are 
several times the diameter of nor-
mal melanosomes, contain varying 
amounts of electron-dense and elec-
tron-lucent globular bodies, and coex-
ist with ultrastructurally normal mela-
nosomes within cells. In melanocytes, 
macromelanosomes also differ from 
normal melanosomes in that they are 
surrounded by a membrane. Large pig-
ment granules transferred to the kerati-
nocytes in café-au-lait patches contain 
singly distributed macromelanosomes 
surrounded by a membrane similar to 
that surrounding aggregates of normal 
melanosomes also found in these cells 
(Jimbow et al., 1973).
Taken together, these studies docu-
menting melanocyte number and giant 
pigment granules in NF1 skin do not 
provide an explanation for a specific 
defect restricted to melanocytes that 
results in the hyperpigmentation of the 
café-au-lait patch. Both the café-au-
lait patches and the non-lesional skin 
of NF1 patients contain macromela-
nosomes, which unfortunately are not 
specific to NF1, having been described 
in melanocytes of a variety of pigmen-
tary disorders (Martuza et al., 1985). 
Both hyperpigmented and normal-
appearing skin also contain increased 
numbers of melanocytes when com-
pared with the skin of unaffected indi-
viduals. The increased density of mela-
nocytes that is consistently observed 
in the skin of NF1 patients is none-
theless interesting and may be in part 
a result of diminished RasGAP activ-
ity in affected melanocytes. Consistent 
with this hypothesis, expression of 
stem cell factor/Kit ligand, the ligand 
for the Kit receptor tyrosine kinase, 
which conveys intracellular signals via 
Ras, results in increased numbers of 
murine intrafollicular melanocytes in 
a transgenic mouse model (Kunisada 
et al., 1998). Additionally, the abnor-
malities in melanocyte density and 
organelle composition that extend to 
the non-lesional skin of these patients 
correlate with the description by 
Riccardi (1992) that even the non-
lesional skin of NF1 patients tends to 
be more pigmented than the skin of 
their unaffected siblings.
The report by De Schepper et al. 
(2006, this issue), demonstrating an 
interaction between neurofibromin 
and β-amyloid precursor protein (APP) 
in human melanocytes, may extend 
our knowledge about the activity 
of neurofibromin in melanocytes to 
lead eventually to an explanation of 
the hyperpigmentation observed in 
café-au-lait patches. APP is a ubiqui-
tously expressed protein that is best 
known as the precursor protein to the 
4-kilodalton peptide amyloid β pro-
tein, linked with Alzheimer's disease. 
Amyloid β protein accumulates extra-
cellularly as a component of senile 
plaques, one of several characteristic 
histopathologic findings in the brain 
tissue of AD patients. The mammalian 
APP belongs to a highly conserved 
family of type 1 integral membrane 
proteins with large extracellular and 
short intracellular domains. APP itself 
has interesting biochemical properties 
as a proteolytic substrate. Most APP 
is cleaved in its extracellular domain 
by an α-secretase, which releases a 
secretory N-terminal domain (sAPPα) 
into the extracellular environment. 
Several members of the ADAM (a dis-
integrin and metalloproteinase) fam-
ily, including ADAM17, ADAM10, 
and ADAM9, may possess this enzy-
matic activity. In contrast, the activ-
ity of a distinct protease β-secretase, 
that cleaves APP N-terminal to the 
previous site, initiates the release of 
the amyloid β protein peptide, whose 
subsequent aggregation is thought to 
be pathogenic in Alzheimer’s disease. 
The human APP gene is alternatively 
spliced, involving exons 7, 8, and 
15, to three major isoforms, APP695, 
APP757, and APP770 (Herzog et al., 
2004; Tanzi and Bertram, 2005).
However, the biology of APP extends 
beyond its expression and putative 
functional role within neurons of the 
central nervous system. High levels 
of APP expression have also been 
described in human epidermis, with 
the main site of expression localized to 
the basal layer (Hoffmann et al., 2000). 
The analysis of APP expression within 
the basal layer of whole-mount prepa-
rations of human epidermis revealed 
that APP expression was significantly 
higher in melanocytes, identified by 
their co-expression of the melanogenic 
enzyme tyrosinase, than in neighbor-
ing keratinocytes (Quast et al., 2003).
De Schepper et al. (2006) identified 
neurofibromin as an interacting part-
ner of APP by yeast two-hybrid screen-
ing and confirmed this interaction by 
co-immunoprecipitation in cultured 
human melanocyte lysate. Further 
exploration of the co-expression of 
these two proteins in melanocytes 
confirmed these results and revealed 
some interesting findings. APP, as 
demonstrated previously (Quast et al., 
2003), was expressed in a perinuclear 
distribution as well as at the dendrite 
tips. Neurofibromin was present in a 
perinuclear distribution, colocalizing 
with the melanosomal marker NKI-
beteb, but was not present in the den-
drite tips. On the ultrastructural level, 
immunogold electron microscopy was 
used to localize both APP and neuro-
fibromin to the melanosome, using 
NKI-beteb as a known melanosomal 
marker. Interestingly, melanocytes 
cultured from the unaffected, non-
lesional skin of an NF1 patient showed 
a marked reduction in the presence of 
both APP and neurofibromin on the 
melanosome. This finding is not only 
consistent with an expected reduction 
of neurofibromin protein in an NF1 
melanocyte but also may imply that 
neurofibromin is functionally impor-
tant for maintaining the melanosomal 
localization or stability of APP. Even 
without these patient-based data, the 
localization of both neurofibromin and 
APP on melanosomes should stimulate 
interest in the potential role of these 
proteins in melanosomal transport.
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In their discussion, De Schepper 
et al. (2006) note how both APP 
and neurofibromin interact with the 
microtubule motor protein kinesin in 
neurons, and how APP is required for 
the transport of an axonal membrane 
compartment in these cells. As kine-
sin is expressed in human melano-
cytes (Hara et al., 2000; Vancoillie et 
al., 2000), their findings are likely to 
prompt inquiries about whether anal-
ogous interactions and mechanisms 
exist in melanocytes for mediating the 
transport of melanosomes via microtu-
bules. It is tantalizing to speculate that 
a macromolecular complex including 
neurofibromin, kinesin, and APP is 
involved in the tethering of the mela-
nosome to the microtubule network to 
promote melanosome transport down 
the dendrite, in much the same way 
that a complex including the small 
GTPase Rab27a, melanophilin, and 
the actin-based vesicle motor myosin-
Va is essential for capture of the mela-
nosome at the dendritic periphery 
(Wu et al., 2002).
Similarly, the localization of neu-
rofibromin to the melanosomal mem-
brane should inspire some questions 
regarding its activity on the melano-
some — especially whether it regu-
lates Ras activity in this location. The 
three ubiquitously expressed Ras iso-
forms H-, K-, and N-Ras exhibit dis-
tinct trafficking routes to the plasma 
membrane. They have been shown 
to signal both from the plasma mem-
brane and from internal membranes, 
such as those of the Golgi apparatus 
and endosomes. Does the localization 
of neurofibromin to the melanosomal 
membrane imply that this membrane, 
of a specialized subcellular organelle 
normally restricted to pigment cells 
and keratinocytes, is also a site of Ras-
dependent signaling? In addition, the 
small guanosine triphosphate-binding 
protein Rab27a, and perhaps other 
small guanosine triphosphate-binding 
proteins such as the Rho family mem-
bers, which mediate melanosome 
phagocytosis in keratinocytes (Scott et 
al., 2003), might be regulated on the 
melanosome as well. This regulation 
could be mediated either by neurofi-
bromin, or by other GTPase-activating 
proteins, such as p190, which regu-
lates the GTPase activity of Rho family 
members and associates with RasGAP 
(Settleman et al., 1992). Another pos-
sible avenue for exploration may be 
the role of sAPPα in the melanosomal 
environment. Membrane-associated 
α-secretase activity might catalyze 
the intracellular release of sAPPα. In 
melanocytes, sAPPα has been shown 
to stimulate activity of dendritic lamel-
lipodia and enhance melanin release 
(Quast et al., 2003). It is not unrea-
sonable to speculate that aspects of 
these processes might be regulated by 
intracellular release of sAPPα from the 
melanosomal membrane, as opposed 
to extracellular release from the plas-
ma membrane or even the membranes 
of neighboring keratinocytes.
In a manner reminiscent of the 
changes in melanocyte density and 
pigment granules previously described 
with non-lesional NF1 melanocytes, 
De Schepper et al. found that both 
neurofibromin and APP were severely 
reduced in melanosomes of melano-
cytes cultured from non-lesional skin 
of a patient with NF1. Hence, obser-
vation of these changes alone is insuf-
ficient to provide a complete explana-
tion for the distinct hyperpigmenta-
tion found within café-au-lait patches. 
To explain the hyperpigmentation of 
café-au-lait patches, it may be neces-
sary to look beyond the melanocyte. In 
one interesting study, secretion of the 
growth factors hepatocyte growth fac-
tor and stem cell factor/Kit ligand from 
fibroblasts underlying café-au-lait 
patches was significantly greater than 
that from fibroblasts underlying non-
lesional skin from either NF1 patients 
or normal individuals (Okazaki et al., 
2002). Both hepatocyte growth fac-
tor and stem cell factor/Kit ligand can 
modulate melanocyte survival, pro-
liferation, and differentiation. In the 
absence of well-defined numerical, 
morphological, or subcellular differ-
ences between melanocytes on the 
lesional and on the non-lesional skin 
of these patients, it seems reasonable 
to propose that some complex inter-
play between abnormal growth factor 
secretion from regional populations of 
fibroblasts and enhanced responsive-
ness of overlying melanocytes to their 
signals may in part account for the 
hyperpigmentation observed in café-
au-lait patches. Perhaps the loss of 
melanosomal neurofibromin and APP 
in NF1 melanocytes is a determinant 
of enhanced melanocyte responsive-
ness to paracrine growth factor stim-
ulation. In any case, the proximity of 
neurofibromin and APP on the mela-
nosome, their physical interaction, 
and the wealth of knowledge about 
APP already obtained from neuronal 
studies should make it possible to 
decipher the functional significance of 
these unique interactions in the mela-
nocyte in the near future.
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